Patents by Inventor Min Ding

Min Ding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8725871
    Abstract: Systems and methods for discovering a set of applications that run on a network are disclosed. In accordance with one method, aggregate traffic volumes are determined for pairs of nodes on the network over a plurality of time intervals. The method further includes building a traffic matrix denoting each of the pairs of nodes and denoting respective aggregate traffic volume histories of each of the pairs of nodes that are based on the determined traffic volumes. In addition, the traffic matrix is formulated as a combination of bases vectors that model the set of applications. The bases vectors are determined by applying a covariance matrix adaptation evolutionary strategy based on the traffic matrix. An indication of the set of applications based on the bases vectors is output.
    Type: Grant
    Filed: October 28, 2011
    Date of Patent: May 13, 2014
    Assignee: NEC Laboratories America, Inc.
    Inventors: Min Ding, Vishal Singh, Yueping Zhang, Guofei Jiang
  • Publication number: 20140108324
    Abstract: Systems and method for modeling system dynamics, including extracting features representative of a temporal evolution of a dynamical system, further including deriving one or more vector trajectories by performing sliding window segmentation of one or more time series; applying a linear test to determine whether the one or more vector trajectories are linear or nonlinear; and performing linear or nonlinear subspace decomposition on the vector trajectory based on the linear test. The system and method may generate a system evolution model from the extracted features of the dynamical system and determine a fitness score of the system evolution model.
    Type: Application
    Filed: October 10, 2013
    Publication date: April 17, 2014
    Applicant: NEC Laboratories America, Inc.
    Inventors: Haifeng Chen, Min Ding, Bin Liu, Abhishek Sharma, Kenji Yoshihira, Guofei Jiang
  • Publication number: 20140108314
    Abstract: A system and method for analysis of complex systems which includes determining model parameters based on time series data, further including profiling a plurality of types of data properties to discover complex data properties and dependencies; classifying the data dependencies into predetermined categories for analysis; and generating a plurality of models based on the discovered properties and dependencies. The system and method may analyze, using a processor, the generated models based on a fitness score determined for each model to generate a status report for each model; integrate the status reports for each model to determine an anomaly score for the generated models; and generate an alarm when the anomaly score exceeds a predefined threshold.
    Type: Application
    Filed: October 10, 2013
    Publication date: April 17, 2014
    Applicant: NEC Laboratories America, Inc.
    Inventors: Haifeng Chen, Min Ding, Bin Liu, Abhishek Sharma, Kenji Yoshihira, Guofei Jiang
  • Publication number: 20140045816
    Abstract: The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
    Type: Application
    Filed: October 8, 2013
    Publication date: February 13, 2014
    Inventors: John A. Bender, Min Ding, Robert G. Gentles, Piyasena Hewawasam
  • Publication number: 20140047279
    Abstract: A computer implemented method for temporal ranking in invariant networks includes considering an invariant network and a set of broken invariants in the invariant network, assuming, for each time point inside a window W, that each metric with broken invariants is affected by a fault at that time point, computing an expected pattern for each invariant of a metric with assumed fault, said pattern indicative of time points at which an invariant will be broken given that its associated metric was affected by a fault at time t, comparing the expected pattern with the pattern observed over the time window W; and determining a temporal score based on a match from the prior comparing
    Type: Application
    Filed: July 25, 2013
    Publication date: February 13, 2014
    Applicant: NEC Laboratories America, Inc.
    Inventors: Abishek Sharma, Heifeng Chen, Min Ding, Kenji Yoshihira, Guofei Jiang
  • Publication number: 20140005233
    Abstract: A composition having clevidipine as an active ingredient is described. The composition includes clevidipine as an active ingredient and an amount of the impurity H168/79 that is no greater than about 1.5%, or where the ratio between clevidipine and H168/79 is equal or above 60 to 1.
    Type: Application
    Filed: June 17, 2013
    Publication date: January 2, 2014
    Applicant: The Medicines Company
    Inventors: Rajeshwar Motheram, Gopal Krishna, Min Ding, Keith Flood, Kornepati Ramakrishna
  • Publication number: 20140001655
    Abstract: A device comprising a substrate, an integrated circuit (IC) die attached to the substrate on one side, a plurality of contact pads on an active side of the IC die, a plurality of thermally and electrically conductive legs, each of the legs attached to a respective one of the contact pads, and an encapsulating material formed around the substrate, the IC die, and a portion of the legs. A contact end of each of the legs is exposed, and one of the contact ends conducts a signal from a transistor in the IC die.
    Type: Application
    Filed: June 29, 2012
    Publication date: January 2, 2014
    Inventor: MIN DING
  • Patent number: 8443080
    Abstract: A method and a system are disclosed for determining application dependency paths in a data center. The method and the system captures application traffic volume data on the servers with switches and monitoring agents; generates an application traffic matrix of all the components of the applications based on the application traffic volume data; estimates the number of the applications in the data center from the traffic matrix with a Rank Estimation via Singular Value Decomposition or Power Factorization Residue Errors process; and decomposes the traffic matrix into a first matrix and a second matrix with a non-negative matrix factorization process using the estimated number of applications. The first matrix represents a set of the components belonging to each of the applications and the second matrix represents the amount of traffic generated by each application over time. Any noise in the first and second matrices is removed with a concurrent volumes ratios based correlation process.
    Type: Grant
    Filed: May 4, 2011
    Date of Patent: May 14, 2013
    Assignee: NEC Laboratories America, Inc.
    Inventors: Min Ding, Vishal Singh, Yueping Zhang, Guofei Jiang
  • Patent number: 8404741
    Abstract: The present disclosure is generally directed to compounds that can inhibit DAGL? and/or ? activity, compositions comprising such compounds, and methods for inhibiting DAGL? and/or ? activity.
    Type: Grant
    Filed: February 11, 2011
    Date of Patent: March 26, 2013
    Assignee: Bristol-Myers Squibb Company
    Inventors: Louis S. Chupak, Xiaofan Zheng, Min Ding, Shuanghua Hu, Yazhong Huang, Robert G. Gentles
  • Patent number: 8383094
    Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
    Type: Grant
    Filed: September 29, 2009
    Date of Patent: February 26, 2013
    Assignee: Bristol-Myers Squibb Company
    Inventors: Makonen Belema, Van N. Nguyen, Michael Serrano-Wu, Denis R. St. Laurent, Yuping Qiu, Min Ding, Nicholas A. Meanwell, Lawrence B. Snyder
  • Patent number: 8354548
    Abstract: The present disclosure is generally directed to compounds that can inhibit DAGL? and/or ? activity, compositions comprising such compounds, and methods for inhibiting DAGL? and/or ? activity.
    Type: Grant
    Filed: February 11, 2011
    Date of Patent: January 15, 2013
    Assignee: Bristol-Myers Squibb Company
    Inventors: Shuanghua Hu, Yazhong Huang, Min Ding, Louis S. Chupak, Xiaofan Zheng, Robert G. Gentles
  • Publication number: 20120322836
    Abstract: Pharmaceutical compositions, and a method of stabilizing pharmaceutical compositions having clevidipine, or any pharmaceutically acceptable salt thereof, as the active ingredient is described. The method includes the slowing down or inhibiting of the oxidation pathway of clevidipine. This can be accomplished by reducing the amount the pharmaceutical composition is exposed to oxygen and/or light during the manufacturing and storing processes. According to this method, oxygen must be removed or replaced, or light must be sufficiently blocked such that light energy cannot reach the active ingredient of the composition, or is reduced to a level that the light-induced oxidation reaction converting clevidipine to H324/78 is minimized, such that the total detectable level of H324/78 in a given composition sample does not exceed about 0.2% on a weight-by-weight basis, or the ratio of clevidipine to H324/78 is equal to or greater than about 450 to 1 on a weight-to-weight basis.
    Type: Application
    Filed: August 30, 2012
    Publication date: December 20, 2012
    Inventors: Gopal Krishna, Rajeshwar Motheram, Min Ding
  • Publication number: 20120320881
    Abstract: Provided is an apparatus and method for allocating time slots to nodes without contention in a wireless network. The method for allotting time slots includes: receiveing a packet length and maximum allowable latencies of the nodes and converting them into data in symbol units; determining a beacon order so that a beacon interval representing a length of a superframe is smaller than or equal to a minimum value of the converted maximum allowable latencies; determining a superframe order so that the sum of a length of a beacon frame, a length of a contention access period, and a length of contention free period is smaller than a length of an active portion, based on the converted packet length; and allocating a guaranteed time slot without contention to each node according to an allocation priority order for the nodes.
    Type: Application
    Filed: December 9, 2011
    Publication date: December 20, 2012
    Applicant: IUCF-HYU (Industry-University Cooperation Foundation Hanyang University)
    Inventors: Seung Ho Hong, Yue Min Ding
  • Publication number: 20120322835
    Abstract: A composition having clevidipine as an active ingredient is described. The composition includes clevidipine as an active ingredient and an amount of the impurity H168/79 that is no greater than about 1.5%, or where the ratio between clevidipine and H168/79 is equal or above 60 to 1.
    Type: Application
    Filed: August 30, 2012
    Publication date: December 20, 2012
    Inventors: Rajeshwar Motheram, Gopal Krishna, Min Ding, Keith Flood, Kornepati Ramakrishna
  • Publication number: 20120191843
    Abstract: Systems and methods for discovering a set of applications that run on a network are disclosed. In accordance with one method, aggregate traffic volumes are determined for pairs of nodes on the network over a plurality of time intervals. The method further includes building a traffic matrix denoting each of the pairs of nodes and denoting respective aggregate traffic volume histories of each of the pairs of nodes that are based on the determined traffic volumes. In addition, the traffic matrix is formulated as a combination of bases vectors that model the set of applications. The bases vectors are determined by applying a covariance matrix adaptation evolutionary strategy based on the traffic matrix. An indication of the set of applications based on the bases vectors is output.
    Type: Application
    Filed: October 28, 2011
    Publication date: July 26, 2012
    Applicant: NEC Laboratories America, Inc.
    Inventors: Min Ding, Vishal Singh, Yueping Zhang, Guofei Jiang
  • Publication number: 20120152355
    Abstract: An organic solar cell is provided. The organic solar cell includes a substrate, a first electrode, a second electrode and a photoelectric conversion layer. The first electrode is disposed on the substrate. The second electrode is disposed on the first electrode. The photoelectric conversion layer is disposed between the first electrode and the second electrode. The photoelectric conversion layer contains a fully conjugated block copolymer including a block having an electron withdrawing group and a block having an electron donating group.
    Type: Application
    Filed: December 30, 2010
    Publication date: June 21, 2012
    Applicant: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Jau-Min Ding, Ching Ting, Shu-Hua Chan
  • Publication number: 20120149770
    Abstract: The invention provides intravenous formulations of propofol in an oil-in-water emulsion, having a combination of preservatives.
    Type: Application
    Filed: October 4, 2011
    Publication date: June 14, 2012
    Applicant: THE MEDICINES COMPANY
    Inventors: Min Ding, Rajeshwar Motheram, Glenn Sblendorio
  • Patent number: 8189164
    Abstract: A modulized display component and a manufacturing method for the same are disclosed in this invention. The display component of this invention is designed according to a modulization concept so that it can be attached to any driving circuit layer. Further, various manufacturing techniques can be used to form the alignment layers and protective layers in order to fabricate a trans-reflective, reflective, or transmissive color displaying component.
    Type: Grant
    Filed: September 11, 2009
    Date of Patent: May 29, 2012
    Assignee: Industrial Technology Research Institute
    Inventors: Chi-Chang Liao, Lung-Pin Hsin, Jau-Min Ding
  • Patent number: 8133884
    Abstract: The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
    Type: Grant
    Filed: May 4, 2009
    Date of Patent: March 13, 2012
    Assignee: Bristol-Myers Squibb Company
    Inventors: Scott W. Martin, Carl P. Bergstrom, Min Ding, Xiaofan Zheng, Robert G. Gentles
  • Publication number: 20110311480
    Abstract: The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
    Type: Application
    Filed: August 31, 2011
    Publication date: December 22, 2011
    Inventors: John A. Bender, Min Ding, Robert G. Gentles, Piyasena Hewawasam